Therefore, we determined that FTO and ALKBH5, which are joint upstream of and regulated by ARHGAP35, can inhibit the malignant progression of NPC by inhibiting cell growth and metastasis. This evidence concerns the gene ALKBH5 and nasopharyngeal carcinoma.